Northwest & Ethical Investments L.P. Sells 800 Shares of Intuitive Surgical, Inc. $ISRG

Northwest & Ethical Investments L.P. trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,177 shares of the medical equipment provider’s stock after selling 800 shares during the quarter. Northwest & Ethical Investments L.P.’s holdings in Intuitive Surgical were worth $8,768,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Correct Capital Wealth Management boosted its holdings in Intuitive Surgical by 66.7% in the 2nd quarter. Correct Capital Wealth Management now owns 500 shares of the medical equipment provider’s stock worth $163,000 after buying an additional 200 shares during the period. J.W. Cole Advisors Inc. raised its holdings in shares of Intuitive Surgical by 232.7% in the 2nd quarter. J.W. Cole Advisors Inc. now owns 22,102 shares of the medical equipment provider’s stock valued at $12,010,000 after acquiring an additional 15,459 shares in the last quarter. North Star Asset Management Inc. lifted its position in Intuitive Surgical by 2.0% during the second quarter. North Star Asset Management Inc. now owns 22,379 shares of the medical equipment provider’s stock valued at $12,161,000 after purchasing an additional 448 shares during the last quarter. FourThought Financial Partners LLC purchased a new position in Intuitive Surgical in the second quarter worth $213,000. Finally, Associated Banc Corp purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth about $309,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $560.00, for a total value of $58,800.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 2,067 shares of Intuitive Surgical stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total value of $1,136,850.00. Following the sale, the vice president owned 473 shares of the company’s stock, valued at approximately $260,150. This trade represents a 81.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 116,164 shares of company stock worth $61,916,172 in the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $574.23 on Thursday. The firm has a fifty day moving average price of $500.48 and a 200-day moving average price of $504.89. The stock has a market cap of $205.85 billion, a PE ratio of 75.96, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.84 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on ISRG shares. Rothschild & Co Redburn raised their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. BTIG Research upped their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Finally, Evercore ISI raised their price target on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.